Literature DB >> 12609222

Epilepsy and multiple sclerosis.

Charles M Poser1, Vesna V Brinar.   

Abstract

A review of 29 published clinical series of adult patients who had epileptic seizures and multiple sclerosis (MS) yielded a prevalence of 2.3%, about three to six times that in the general adult population. The probable anatomic basis for the seizures is areas of inflammation, edema, and/or demyelination in the cerebral cortex and the juxtacortical white matter generated by a mechanism that is not completely understood; the fact that these plaques are very common suggests that other factors must operate in view of the rarity of seizures in MS. Seizures have been observed before and presumably marking the clinical onset of the disease, and during acute bouts. In some instances convulsions appear to be the only manifestations of an attack of MS, but there is no general acceptance of seizures as the first and only symptoms of the disease. The coincidental occurrence of both diseases, the nonspecific triggering effect of MS on latent epilepsy, and actual causation by MS are all possible explanations, but the last named is, in our opinion, extremely unusual.

Entities:  

Mesh:

Year:  2003        PMID: 12609222     DOI: 10.1016/s1525-5050(02)00646-7

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  21 in total

Review 1.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Chronic demyelination-induced seizures.

Authors:  Andrew S Lapato; Jenny I Szu; Jonathan P C Hasselmann; Anna J Khalaj; Devin K Binder; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2017-01-30       Impact factor: 3.590

Review 3.  Connexins and pannexins: At the junction of neuro-glial homeostasis & disease.

Authors:  Andrew S Lapato; Seema K Tiwari-Woodruff
Journal:  J Neurosci Res       Date:  2017-06-05       Impact factor: 4.164

4.  Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Authors:  Lisa Langenbruch; Julia Krämer; Sati Güler; Gabriel Möddel; Sophia Geßner; Nico Melzer; Christian E Elger; Heinz Wiendl; Thomas Budde; Sven G Meuth; Stjepana Kovac
Journal:  J Neurol       Date:  2019-05-08       Impact factor: 4.849

5.  Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.

Authors:  Massimiliano Calabrese; Nicola De Stefano; Matteo Atzori; Valentina Bernardi; Irene Mattisi; Luigi Barachino; Luciano Rinaldi; Aldo Morra; Matthew M J McAuliffe; Paola Perini; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2008-01-31       Impact factor: 4.849

6.  Vitamin B₁₂ deficiency: an unusual cause for recurrent generalised seizures with pancytopaenia.

Authors:  Kushal Naha; Sowjanya Dasari; G Vivek; Mukhyaprana Prabhu
Journal:  BMJ Case Rep       Date:  2012-09-03

Review 7.  Clinical correlates of grey matter pathology in multiple sclerosis.

Authors:  Dana Horakova; Tomas Kalincik; Jana Blahova Dusankova; Ondrej Dolezal
Journal:  BMC Neurol       Date:  2012-03-07       Impact factor: 2.474

Review 8.  Neuroinflammation: A Signature or a Cause of Epilepsy?

Authors:  Enrico Pracucci; Vinoshene Pillai; Didi Lamers; Riccardo Parra; Silvia Landi
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

9.  Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.

Authors:  Michele Jara; Graham Barker; Herbert R Henney
Journal:  Neuropsychiatr Dis Treat       Date:  2013-03-10       Impact factor: 2.570

10.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.